Andrew Goodman will Join Paul Hastings as Partner on August 19

In a move that further strengthens the firm’s M&A and premier shareholder activism platform, Paul Hastings LLP today announced that Andrew H. Goodman will join the firm as a partner on Monday, August 19.

Goodman, who will work out of the firm’s Boston and New York offices, focuses on public company M&A, corporate governance, shareholder activism defense, and contested situations. He advises clients across sectors with deep experience in life sciences, technology, and real estate investment trust M&A.

“It is a strategic priority to continue strengthening our capabilities supporting the C-suite and boards of public companies on their most complex and important matters. Andrew’s extensive experience in public M&A and shareholder activism, particularly in the life sciences and technology sectors, enhances our ability to serve premier clients and gain market share at the top of the market,” said firm Chair Frank Lopez.

Paul Hastings has vaulted to #2 in FactSet’s Company Defense Top Law Firms league tables over the past year. The firm also is one of only eight Chambers-ranked firms for Corporate/M&A: Takeover Defense and among the leaders in The Legal 500.

Ranked by The Legal 500 for his work in shareholder activism defense, Goodman advises clients on fiduciary and governance matters, as well as diverse contests for corporate control, including election contests and opposition to transactions. He has worked with clients such as Forma Therapeutics, Ipsen Pharmaceuticals, iRobot, LaSalle Hotel Properties, Parexel, Teva Pharmaceuticals, WisdomTree Investments, Xoom, and Zoll Medical.

“My public company M&A and activism defense practices are synergistic with the offerings of Paul Hastings and its growing elite global transactional platform,” said Goodman, who joins from Goodwin Procter LLP. “I’m excited to serve the firm’s top-flight clients and to introduce my clients to the incredibly talented lawyers across the firm.”

Over the past 18 months, Paul Hastings has been building across private equity and corporate M&A and shareholder activism defense with premier talent. Additions include a three-partner team led by Scott Joachim, co-chair of private equity, in Palo Alto and New York; a seven-lawyer private equity buyout team led by Alex Temel, co-chair of private equity, and Bill Schwab in Boston; an insurance M&A team including partners Kirk Lipsey, Chad Vance, and Sanjiv Tata, along with Brad Drake, in New York and Chicago; private equity vice chair Josh Ratner in New York; a three-partner, seven-lawyer Chambers-ranked corporate team including David Elder, Chris Centrich, and Patrick Hurley in Houston; Frederik Mühl and Nikolaos Paschos, chair of German M&A, in Frankfurt; Sean Donahue, chair of public company advisory and co-chair of shareholder activism & takeover defense, in Washington, D.C.; and M&A partner Jon Kubek in New York.